Clinical Trials Browser

Phase 2 × Active not recruiting × taletrectinib × Clear all

NCT04919811 2026-01-07

TRUST-II

Phase 2 Active not recruiting

217 enrolled 1 FDA

Carcinoma, Non-Small-Cell Lung